Trimi Health review
Named pharmacy, cited trials
Names its compounding pharmacy with its state license number and quotes the trials it cites verbatim — then sells the result at one of the lowest prices on this board.
Our verdict
Trimi does the two things this category almost never does at once: it is cheap, and it shows its work. Compounded semaglutide is $99 a month and tirzepatide $125, both on an annual plan, both flat at every dose. Its dispensing pharmacies are named with a state license number you can check — VialsRx, Texas Board of Pharmacy #35264, and GreenwichRx — and its medical director is a named, board-certified physician. Most striking, it quotes STEP-1 and SURMOUNT-1 word for word with full NEJM citations and then states, unprompted, that those figures come from trials of the branded drugs and not of the compounded preparations it sells. Almost nobody on this board draws that line. What it sells is narrow: two compounded molecules, no branded route, no insurance.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 telehealth
- Access
- Compounded GLP-1 from ~$99/mo, all 50 states
- Medications
- Semaglutide · Tirzepatide · Branded · Retatrutide
- Insurance
- Cash-pay, no insurance
- Visit
- Async intake
- Availability
- All 50 states claimed; no list published
- Updated
- August 2026
Sponsored alternative
Enhance MD
Lab-guided treatment under ongoing physician oversight
Check Enhance MD availability →What it is
A GLP-1-only telehealth service, and the focus is deliberate. Trimi's public catalog is two products — compounded semaglutide and compounded tirzepatide, both once-weekly injections — with no branded option, no oral formulation and no investigational agent listed. Clinical care runs through Arora Health, a 50-state provider network led by Dr. Sean Arora, MD, its founder and Trimi's medical director, with Dr. Shannon Arora, MD as chief medical officer. Dispensing is done by 503A sterile compounding pharmacies that Trimi names outright, with a certificate of analysis available on request.
How it works
An online intake, review by a licensed provider from the Arora Health network usually within 24 hours, then free overnight shipping, with most orders arriving in two to four days. There are no appointments and no video visit in the published path. One flat monthly price is stated to cover clinical care, the medication, ongoing check-ins, dose titration and shipping, with unlimited provider messaging between visits and a patient portal for refills and dose changes. If the medical team does not approve you, Trimi says the refund is automatic. It also offers a six-month money-back promise — follow the plan for six months without losing weight and you can request a refund — flagged with "terms apply," which is where the substance of any such promise lives. Klarna and Afterpay are accepted at checkout, which is worth pausing on: financing a recurring medical subscription is a different decision from financing a purchase.
Pricing transparency
Compounded semaglutide is $99 a month and compounded tirzepatide $125, and the qualifier travels with both figures on Trimi's own pages: those are annual-plan prices. The structural promises around them are the ones that decide what you actually pay. The price is the same at every dose, so titrating up does not raise the bill — the single most common way a cheap first month becomes an expensive sixth one elsewhere. And one flat membership is stated to include the medication, clinician visits, ongoing check-ins and free overnight shipping, with no separate consultation fee and no membership charged beside the medication. Insurance is not accepted or needed; FSA and HSA funds are eligible. Confirm what the month-to-month rate is if you do not want to commit for a year.
Branded vs compounded
Compounded semaglutide and compounded tirzepatide, prepared per individual prescription by a named 503A pharmacy and, in Trimi's own words, not FDA-approved as drugs. Its evidence handling is the best on this board. It quotes STEP-1 directly — a mean body-weight change of −14.9% against −2.4% on placebo at 68 weeks, cited to Wilding et al., NEJM 2021 — and SURMOUNT-1 at −20.9% against −3.1% at 72 weeks, cited to Jastreboff et al., NEJM 2022, and then states that these are trial averages for the branded formulations rather than for compounded preparations. It also publishes the risks in the same breath: nausea, vomiting, diarrhea and constipation as common effects, pancreatitis, gallbladder disease and kidney injury as serious ones, the boxed warning for thyroid C-cell tumors, and the histories that rule treatment out. The marketing does round its own citations up — product cards read "up to 22%" and "up to 16%" beside comparison-table figures of 20.9% and 14.9% — so read the table rather than the card.
Pros and watch-outs
What we like
- $99 a month for compounded semaglutide and $125 for tirzepatide, with the annual-plan qualifier stated beside the number rather than buried
- Same price at every dose, so the bill does not rise as you titrate
- Names its dispensing pharmacies — VialsRx, Texas Board of Pharmacy license #35264, and GreenwichRx — with a certificate of analysis available on request
- Names its medical director and chief medical officer, both physicians, and the 50-state network behind them
- Quotes STEP-1 and SURMOUNT-1 verbatim with full NEJM citations, then states the figures are for the branded drugs and not the compounded product
- Publishes the boxed warning, the serious risks and the contraindications rather than only the common side effects
- One flat membership covers medication, clinician visits, check-ins, dose adjustments and free overnight shipping
- Automatic refund if the medical team does not approve you; a six-month money-back promise on top
- FSA and HSA eligible
Watch-outs
- The $99 and $125 headlines are annual-plan prices; the month-to-month rate is not published beside them
- Two products only — no branded GLP-1, no oral formulation, no insurance route
- Product cards round the trial numbers up to 22% and 16% over the 20.9% and 14.9% its own comparison table cites
- The six-month money-back promise is qualified as "terms apply," and those terms are not on the page
- Klarna and Afterpay financing on a recurring prescription is a commitment that outlives the checkout
- The 50-state claim is the network's own; no state list is published
- Compounded preparations are not FDA-approved and are not therapeutically equivalent to Wegovy, Ozempic, Mounjaro or Zepbound
Best for
Cost-conscious readers who want the lowest flat price on this board from a service that will tell them which pharmacy filled it and which trial the number came from.
Who should look elsewhere
Anyone who wants a branded GLP-1, an oral option, insurance billing, or a month-to-month price they can see before committing to a year.
The evidence behind what Trimi Health prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
- SURMOUNT-1 explained: the trial that made tirzepatide the benchmark
The landmark phase 3 trial of tirzepatide for obesity — the design, the up-to-20.9% weight loss, the safety profile, and the limits of what it proved.
- Tirzepatide vs semaglutide for weight loss: what the trials actually support
Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.
How Trimi Health compares
A few alternatives worth a look, depending on what you’re optimizing for.
yourEraA low-cost entry point into compounded GLP-1 treatment
See yourEra →- HealthRX
Low-cost compounded GLP-1 with overnight shipping and physician review
See HealthRX → 
CoreAge RxFlat pricing that does not climb as your dose titrates up
See CoreAge Rx →
More GLP-1 telehealth reviews: Superior RemediesNoviFeelGoodRoHims & HersHenry Meds
Access & cost · Reviewed and last verified August 2026
How we assessed this. This review reflects Aminoscope’s own read of Trimi Health’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- How much does Trimi cost?
- Compounded semaglutide is $99 a month and compounded tirzepatide $125, both quoted on the annual plan — Trimi states that qualifier beside the figures rather than hiding it in a footnote. The price is the same at every dose, and one flat membership is stated to cover the medication, clinician visits, ongoing check-ins, dose adjustments and free overnight shipping. Ask what the month-to-month rate is if you would rather not commit for a year.
- Which pharmacy compounds Trimi's medication?
- VialsRx, licensed by the Texas State Board of Pharmacy under number 35264, or GreenwichRx — both named openly as 503A sterile compounding pharmacies, with a certificate of analysis available on request. A license number you can look up is a materially stronger disclosure than the "licensed U.S. compounding pharmacy" most of this board offers.
- What does Trimi actually prescribe?
- Two compounded medications and nothing else: semaglutide and tirzepatide, both once-weekly injections, prepared per individual prescription. There is no branded option, no oral formulation and no investigational agent in its public catalog. Compounded preparations are not FDA-approved as drugs and are not therapeutically equivalent to Wegovy, Ozempic, Mounjaro or Zepbound.
- Is the six-month money-back promise worth counting on?
- Read the terms before you do. Trimi says that if you follow your plan for six months and do not lose weight you can request a refund, and marks the offer "terms apply" without setting those terms out on the page. Guarantees of this shape usually turn on dose adherence, logged check-ins and a claim window. The separate promise — an automatic refund if the medical team does not approve you — is simpler and easier to rely on.
- Is Trimi Health legit?
- Trimi Health is a GLP-1 telehealth service you reach through an online intake a clinician reviews. The medications it names are Semaglutide, Tirzepatide, branded medication and Retatrutide. Its stated availability: All 50 states claimed; no list published. What it publishes up front: Compounded GLP-1 from ~$99/mo, all 50 states. It is cash-pay and states it does not bill insurance. Those are the provider's own published claims rather than checks we could run ourselves, so get the ones that matter to you confirmed in writing before you pay.
- Is Trimi Health expensive compared with other GLP-1 telehealth providers?
- Trimi Health publishes a starting figure of $99/mo. Across the 42 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $269 with a median of $179, which puts Trimi Health below the median, toward the cheaper end. The other 31 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.